Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3029% below fair value
$61.35−1.58 (-2.51%)
Close on Nov 17, 2026Market cap $125.40BP/E 13.6Yield 4.06%
Bristol Myers Squibb enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bristol Myers Squibb's enterprise value was $160.59B on Nov 11, 2026, against $132.73B a year earlier. Over the last 5 years it ranged from $118.80B to $204.16B, with a median of $159.69B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $160.59B | +12.8% |
| 2025 | Dec 31, 2025 | $142.39B | -9.0% |
| 2024 | Dec 31, 2024 | $156.47B | +13.6% |
| 2023 | Dec 29, 2023 | $137.69B | -26.0% |
| 2022 | Dec 30, 2022 | $186.08B | +11.0% |
| 2021 | Dec 31, 2021 | $167.65B | +5.3% |
| 2020 | Dec 31, 2020 | $159.15B | +63.1% |
| 2019 | Dec 31, 2019 | $97.55B | +13.7% |
| 2018 | Dec 31, 2018 | $85.77B | -17.0% |
| 2017 | Dec 29, 2017 | $103.31B | +3.7% |
| 2016 | Dec 30, 2016 | $99.66B | -15.0% |
| 2015 | Dec 31, 2015 | $117.23B | +18.4% |
| 2014 | Dec 31, 2014 | $99.03B | +6.8% |
| 2013 | Dec 31, 2013 | $92.71B | +53.6% |
| 2012 | Dec 31, 2012 | $60.37B | +4.2% |
| 2011 | Dec 30, 2011 | $57.91B | – |
See a number that looks wrong?